Skip to main content

Prähospitale Antikoagulation bei Patienten mit akutem Koronarsyndrom und chronischer Therapie mit oralen Antikoagulanzien

Prehospital anticoagulation therapy in patients with acute coronary syndromes on chronic therapy with oral anticoagulants

The Original Article was published on 23 May 2022

This is a preview of subscription content, access via your institution.

Literatur

  1. Windecker S, Kolh P, Alfonso F, Collet JP, Cremer J, Falk V, Filippatos G, Hamm C, Head SJ, Jüni P, Kappetein AP, Kastrati A, Knuuti J, Landmesser U, Laufer G, Neumann FJ, Richter DJ, Schauerte P, Sousa Uva M, Stefanini GG, Taggart DP, Torracca L, Valgimigli M, Wijns W, Witkowski A (2014) 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 35:2541–2619

    Article  Google Scholar 

  2. Meng S, Xu J, Guo L, Huang R (2020) Clinical outcomes of bivalirudin versus heparin in elderly patients undergoing PCI. A systematic review and meta-analysis of randomized controlled trials. Cardiovasc Drugs Ther 34:101–111

    CAS  Article  Google Scholar 

  3. Liem A, Zijlstra F, Ottervanger JP, Suryapranata H, de Boer MJ, Verheugt FWA (2000) High dose heparin as pretreatment for primary angioplsaty in acute myocardial infarction: the Heparin in Early Patency (HEAP) randomized trial. J Am Coll Cardiol 35:600–604

    CAS  Article  Google Scholar 

  4. Collet JP, Huber K, Cohen M, Zeymer U, Goldstein P, Pollack C Jr, Silvain J, Henry P, Varenne O, Carrié D, Coste P, Angioi M, Le Breton H, Cayla G, Elhadad S, Teiger E, Filippi E, Aout M, Vicaut E, Montalescot G, ATOLL Investigators (2013) A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial). Am J Cardiol 112:1367–1372

    CAS  Article  Google Scholar 

  5. Karjalainen PP, Vikman S, Niemelä M, Porela P, Ylitalo A, Vaittinen MA, Puurunen M, Airaksinen TJ, Nyman K, Vahlberg T, Airaksinen KE (2008) Safety of percutaneous coronary intervention during uninterrupted oral anticoagulant treatment. Eur Heart J 29:1001–1010

    Article  Google Scholar 

  6. Vranckx P, Leebeek FW, Tijssen JG, Koolen J, Stammen F, Herman JP, de Winter RJ, van T Hof AW, Backx B, Lindeboom W, Kim SY, Kirsch B, van Eickels M, Misselwitz F, Verheugt FW (2015) Peri-procedural use of rivaroxaban in elective percutaneous coronary intervention to treat stable coronary artery disease. The XPLORER trial. Thromb Haemost 114:258–267

    CAS  Article  Google Scholar 

  7. Hamm CW, Schneck E, Buerke M et al. (2021) Empfehlungen zur prähospitalen Behandlung des akuten Koronarsyndroms bei Patienten unter Dauertherapie mit neuen oralen Antikoagulanzien (NOAKs). Kardiologe 15:32–37

    CAS  Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Uwe Zeymer.

Ethics declarations

Interessenkonflikt

U. Zeymer, R. Brütsch und R. Zahn geben an, dass kein Interessenkonflikt besteht.

Additional information

figure qr

QR-Code scannen & Beitrag online lesen

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zeymer, U., Brütsch, R. & Zahn, R. Prähospitale Antikoagulation bei Patienten mit akutem Koronarsyndrom und chronischer Therapie mit oralen Antikoagulanzien. Notfall Rettungsmed 25, 273–274 (2022). https://doi.org/10.1007/s10049-022-01041-9

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10049-022-01041-9